Clinical Trial Update: ONO-4059 Study in Patients With Steroid-resistant Pemphigus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ONO-4059 for steroid-resistant pemphigus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Drugs mentioned

• ONO-4059

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Pemphigus, Steroid-resistant Pemphigus | Phase 3 | Status: RECRUITING